Neuraxis, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.1% | 13.6% | 11.6% | 12.0% | 14.6% | 13.8% | 15.6% | 16.4% | 16.7% | 14.6% | 13.6% | 14.1% | 14.4% | |
| 85.9% | 86.4% | 88.4% | 88.0% | 85.4% | 86.2% | 84.4% | 83.6% | 83.3% | 85.4% | 86.4% | 85.9% | 85.6% | |
| 9.4% | 0.4% | 0.9% | 8.9% | 10.9% | 9.7% | 6.8% | 6.5% | 16.1% | 25.2% | 6.2% | 14.2% | 14.1% | |
| 696.0% | 378.6% | 358.5% | 429.8% | 308.0% | 256.3% | 319.0% | 253.3% | 232.0% | 109.3% | 137.2% | 137.1% | 146.6% | |
| 718.9% | 391.8% | 371.7% | 448.9% | 333.1% | 278.9% | 340.7% | 275.7% | 342.1% | 262.7% | 194.7% | 196.0% | 230.1% | |
| -633.0% | -305.4% | -283.3% | -360.9% | -247.7% | -192.7% | -256.2% | -192.1% | -258.8% | -177.3% | -108.3% | -110.2% | -144.5% | |
| 300.3% | 4.2% | 7.5% | 23.6% | 15.8% | 0.3% | 0.2% | 1.5% | 3.7% | 3.0% | 1.6% | 1.0% | 2.0% | |
| -1,806.5% | -999.8% | -328.0% | -477.1% | -263.3% | -190.2% | -254.4% | -189.1% | -261.6% | -176.5% | -109.5% | -108.1% | -144.4% | |
| 302.0% | 4.7% | 3.8% | -70.2% | – | – | – | – | – | – | – | – | – | |
| -1,806.5% | -999.8% | -328.0% | -477.1% | -263.3% | -190.2% | -254.4% | -189.1% | -261.6% | -176.5% | -109.5% | -118.1% | -148.0% | |
| -1,504.1% | -303.4% | -318.8% | -451.7% | -246.1% | -189.0% | -253.5% | -186.1% | -256.0% | -171.0% | -106.9% | -106.3% | -141.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.